XOMA Corp (XOMA)
25.13
-0.67
(-2.60%)
USD |
NASDAQ |
Jun 21, 16:00
25.14
+0.01
(+0.04%)
After-Hours: 20:00
XOMA Accounts Receivable (Quarterly): 0.003M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.003M |
December 31, 2023 | 1.004M |
September 30, 2023 | 0.043M |
June 30, 2023 | 0.901M |
March 31, 2023 | 0.006M |
December 31, 2022 | 0.001M |
September 30, 2022 | 0.016M |
June 30, 2022 | 0.005M |
March 31, 2022 | 0.025M |
December 31, 2021 | 0.209M |
September 30, 2021 | 0.518M |
June 30, 2021 | 0.012M |
March 31, 2021 | 0.08M |
December 31, 2020 | 0.263M |
September 30, 2020 | 0.222M |
June 30, 2020 | 0.411M |
March 31, 2020 | 1.312M |
December 31, 2019 | 2.933M |
September 30, 2019 | 3.783M |
June 30, 2019 | 2.577M |
March 31, 2019 | 2.755M |
December 31, 2018 | 1.468M |
September 30, 2018 | 1.315M |
June 30, 2018 | 0.48M |
March 31, 2018 | 0.436M |
Date | Value |
---|---|
December 31, 2017 | 0.397M |
September 30, 2017 | 1.026M |
June 30, 2017 | 10.63M |
March 31, 2017 | 1.343M |
December 31, 2016 | 0.566M |
September 30, 2016 | 0.756M |
June 30, 2016 | 0.959M |
March 31, 2016 | 1.977M |
December 31, 2015 | 3.718M |
September 30, 2015 | 39.34M |
June 30, 2015 | 2.649M |
March 31, 2015 | 3.271M |
December 31, 2014 | 2.993M |
September 30, 2014 | 3.42M |
June 30, 2014 | 5.51M |
March 31, 2014 | 4.312M |
December 31, 2013 | 3.731M |
September 30, 2013 | 5.63M |
June 30, 2013 | 7.293M |
March 31, 2013 | 6.27M |
December 31, 2012 | 7.477M |
September 30, 2012 | 7.005M |
June 30, 2012 | 6.386M |
March 31, 2012 | 10.16M |
December 31, 2011 | 11.82M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.001M
Minimum
Dec 2022
3.783M
Maximum
Sep 2019
0.7162M
Average
0.2155M
Median
Accounts Receivable (Quarterly) Benchmarks
Viracta Therapeutics Inc | -- |
AbbVie Inc | 11.95B |
AnaptysBio Inc | 7.089M |
Cue Biopharma Inc | 1.40M |
NovaBay Pharmaceuticals Inc | 0.734M |